Impact of medical insurance access negotiation on the utilization of innovative anticancer drugs in China: an interrupted time series analysis by Cui Li, Jingmin Zhu, Linghan Shan, Yingyu Zhou, Gang Liu, Hong Zhu, Qunhong Wu, Yu Cui, Zheng Kang

Connect to this object online.

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study by Hong Zhu, Hong Zhu, Hong Zhu, Jingmin Zhu, Jingmin Zhu, Jingmin Zhu, Yingyu Zhou, Linghan Shan, Linghan Shan, Cui Li, Cui Li, Cui Li, Yu Cui, Yu Cui, Zheng Kang, Zheng Kang, Mingli Jiao, Mingli Jiao, Huan Liu, Huan Liu, Lijun Gao, Lijun Gao, Qunhong Wu, Qunhong Wu, Yanhua Hao, Yanhua Hao

Connect to this object online.